Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients--United States, April 2021

Authors :: MacNeil, Jessica R.
Su, John R.
Broder, Karen R.
Guh, Alice Y.
Gargano, Julia W.
Wallace, Megan
Hadler, Stephen C.
Scobie, Heather M.
Blain, Amy E.
Moulia, Danielle
Daley, Matthew F.
McNally, Veronica V.
Romero, Jose R.
Talbot, H. Keipp
Lee, Grace M.
Bell, Beth P.
Oliver, Sara E.
Source :: Morbidity and Mortality Weekly Report. April 30, 2021, Vol. 70 Issue 17, p651, 6 p.
Publication Year :: 2021
Abstract: On April27, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency [...]

Subjects :: United States. Food and Drug Administration -- Reports
United States. Department of Health and Human Services -- Reports
Johnson & Johnson -- Reports
Blood clot -- Complications and side effects
Thrombosis -- Complications and side effects
Medical colleges -- Usage -- Reports
Vaccines -- Usage -- Complications and side effects
Pharmaceutical industry -- Reports -- Usage
Health

Tools